» Authors » Dhananjay Suresh

Dhananjay Suresh

Explore the profile of Dhananjay Suresh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 95
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mukherjee S, Suresh D, Zambre A, Yadavilli S, Ghoshdastidar S, Upendran A, et al.
Cancers (Basel) . 2025 Feb; 17(3). PMID: 39941857
Background/objectives: KRAS-mutated NSCLC has been targeted using monoclonal antibody (mAb) or tyrosine kinase inhibitor (TKI) therapies. However, in time, these mutations appear to develop resistance against the targeted antibodies and...
2.
Gangula A, Suresh D, Babu A, Li Z, Upendran A, Kannan R
Bioact Mater . 2024 Nov; 40:557-570. PMID: 39539730
RNAi therapeutics possess the potential to cure many uncurable human diseases. For instance, RNAi therapeutics using liposomes showed remarkable survival benefits in patients with liver diseases. However, the extension of...
3.
Romero M, Gelsomini A, Miller K, Suresh D, Thaller S, Frasca D
J Nutr . 2024 Oct; 155(2):445-452. PMID: 39389182
Background: Our previous work has shown that senescent B cells accumulate in the human adipose tissue (AT) of people with obesity, where they express transcripts for markers associated with the...
4.
Romero M, Miller K, Gelsomini A, Garcia D, Li K, Suresh D, et al.
Nat Commun . 2024 Aug; 15(1):7515. PMID: 39209820
Aging is characterized by chronic systemic inflammation and metabolic changes. We compare the metabolic status of B cells from young and elderly donors and found that aging is associated with...
5.
Romero M, Miller K, Gelsomini A, Garcia D, Li K, Suresh D, et al.
medRxiv . 2023 Aug; PMID: 37609164
Aging is characterized by chronic systemic inflammation and metabolic changes. When we compared B cells from young and elderly donors, we found that aging induces higher oxygen consumption rates, and...
6.
Suresh D, Suresh A, Kannan R
Bioact Mater . 2022 Apr; 18:321-336. PMID: 35415301
The size of nanocarriers determines the biological property of the materials, especially as it relates to intratumoral distribution. Previous research has shown that sizes of 10-50 nm penetrate deep inside...
7.
Lyu Z, Ghoshdastidar S, Rekha K, Suresh D, Mao J, Bivens N, et al.
Sci Rep . 2021 Mar; 11(1):6558. PMID: 33753813
Due to their antimicrobial properties, silver nanoparticles (AgNPs) are used in a wide range of consumer products that includes topical wound dressings, coatings for biomedical devices, and food-packaging to extend...
8.
Suresh D, Jenkins B, Zambre A, Upendran A, Kannan R
J Biomed Nanotechnol . 2020 Dec; 16(7):1169-1181. PMID: 33308383
Developing a delivery vehicle to protect siRNA from degradation is a significant challenge. To solve this challenge, researchers attempted to use protein-based nanoparticles to deliver siRNA with limited to moderate...
9.
Suresh D, Ghoshdastidar S, Gangula A, Mukherjee S, Upendran A, Kannan R
ACS Omega . 2020 Sep; 5(37):23724-23735. PMID: 32984691
Current methods for capturing circulating tumor cells (CTCs) are based on the overexpression of cytokeratin (CK) or epithelial cell-adhesion molecule (EpCAM) on cancer cells. However, during the process of metastasis,...
10.
Suresh D, Zambre A, Mukherjee S, Ghoshdastidar S, Jiang Y, Joshi T, et al.
Nanomedicine . 2019 May; 20:102007. PMID: 31085346
Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality with the 5-year survival rate at a dismal 16% for the past 40 years. Drug resistance is a...